Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Britt Falskov; Thomas Steffen Hermann; Jakob Raunsø; Buris Christiansen; Christian Rask-Madsen; Atheline Major-Pedersen; Lars Køber; Christian Torp-Pedersen; Maria Helena Dominguez Vall-Lamora

doi:10.1186/1475-2840-10-91

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Britt Falskov, Thomas Steffen Hermann, Jakob Raunsø, Buris Christiansen, Christian Rask-Madsen, Atheline Major-Pedersen, Lars Køber, Christian Torp-Pedersen, Maria Helena Dominguez Vall-Lamora

Department of Oncology

10 Citations (Scopus)

Abstract

Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothelial function, 24 hour ambulatory blood pressure and heart rate during treatment with carvedilol, metoprolol tartrate and metoprolol succinate in patients with HF.

Original language	English
Journal	Cardiovascular Diabetology
Volume	10
Pages (from-to)	91
ISSN	1475-2840
DOIs	https://doi.org/10.1186/1475-2840-10-91
Publication status	Published - 2011

Access to Document

10.1186/1475-2840-10-91

Cite this

Falskov, B., Hermann, T. S., Raunsø, J., Christiansen, B., Rask-Madsen, C., Major-Pedersen, A., Køber, L., Torp-Pedersen, C., & Dominguez Vall-Lamora, M. H. (2011). Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study. Cardiovascular Diabetology, 10, 91. https://doi.org/10.1186/1475-2840-10-91

@article{e3c66adae0b94936a1228efa36839555,

title = "Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study",

abstract = "Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothelial function, 24 hour ambulatory blood pressure and heart rate during treatment with carvedilol, metoprolol tartrate and metoprolol succinate in patients with HF.",

author = "Britt Falskov and Hermann, \{Thomas Steffen\} and Jakob Rauns{\o} and Buris Christiansen and Christian Rask-Madsen and Atheline Major-Pedersen and Lars K{\o}ber and Christian Torp-Pedersen and \{Dominguez Vall-Lamora\}, \{Maria Helena\}",

year = "2011",

doi = "10.1186/1475-2840-10-91",

language = "English",

volume = "10",

pages = "91",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

AU - Falskov, Britt

AU - Hermann, Thomas Steffen

AU - Raunsø, Jakob

AU - Christiansen, Buris

AU - Rask-Madsen, Christian

AU - Major-Pedersen, Atheline

AU - Køber, Lars

AU - Torp-Pedersen, Christian

AU - Dominguez Vall-Lamora, Maria Helena

PY - 2011

Y1 - 2011

N2 - Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothelial function, 24 hour ambulatory blood pressure and heart rate during treatment with carvedilol, metoprolol tartrate and metoprolol succinate in patients with HF.

AB - Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothelial function, 24 hour ambulatory blood pressure and heart rate during treatment with carvedilol, metoprolol tartrate and metoprolol succinate in patients with HF.

UR - https://www.scopus.com/pages/publications/80053972869

U2 - 10.1186/1475-2840-10-91

DO - 10.1186/1475-2840-10-91

M3 - Journal article

C2 - 21999413

SN - 1475-2840

VL - 10

SP - 91

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

ER -

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this